Trademark: 90221395
Word
DIZAL
Status Date
Tuesday, November 1, 2022
Registration Number
6890229
Registration Date
Tuesday, November 1, 2022
Filing Date
Tuesday, September 29, 2020
Published for Opposition
Tuesday, January 4, 2022
5 Preparations for destroying noxious animals; antiseptics; bacterial culture mediums; bouillons for bacteriological cultures; media for bacteriological cultures; bacterial poisons; balsamic preparations for medical purposes; insecticides; medicinal preparations for the mouth to be applied in the form of capsules; pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; chemico-pharmaceutical preparations for treatment of human illnesses, namely, anti-tumor treatment; collyrium; medicines for alleviating constipation; solutions for contact lenses; radiological contrast substances for medical purposes; depuratives for the body; digestives for pharmaceutical purposes; analgesics; drugs for medical purposes for treatment of human illnesses, namely, anti-tumor treatment; filled portable medicine cases, comprised of pharmaceuticals for treatment of human illnesses, namely, anti-tumor treatment; pharmaceutical preparations, namely, elixirs for anti-tumor treatment; mineral, bath and sodium salts for medical purposes; esters for pharmaceutical purposes; ethers for pharmaceutical purposes; fungicides; gelatine for medical purposes, namely, gelatin capsules sold empty; germicides; chewing gum for medical purposes; medicated lozenges for pharmaceutical purposes; cough pastilles for pharmaceutical purposes; rat poison; antibiotic, sunburn and anti-inflammatory ointments for pharmaceutical purposes; organotherapy preparations; opotherapy preparations; pharmaceutical preparations for skin care; herbal teas for medicinal purposes; cachets in the nature of capsules for medicinal preparations for the mouth for pharmaceutical purposes; first-aid boxes, filled; blood plasma; radioactive substances for medical purposes; tonics being pharmaceutical preparations for the treatment of human illnesses, namely, anti-tumor treatment; blood for medical purposes; sterilizing preparations; styptic preparations; aluminum acetates for pharmaceutical purposes; acids for pharmaceutical purposes; dietetic foods adapted for medical purposes; biological preparations for medical purposes for treatment of human illnesses; dietetic beverages adapted for medical purposes; crystallized rock sugar for medical purposes; candy for medical purposes; cellulose esters for pharmaceutical purposes; cellulose ethers for pharmaceutical purposes; by-products of the processing of cereals for dietetic or medical purposes; chemical preparations for pharmaceutical purposes for the treatment of human illnesses, namely, anti-tumor treatment; medicines for dental purposes; anti-allergic and pain reduction medicines for treatment of illnesses for human purposes; diagnostic preparations for medical purposes; medicinal drinks; petroleum jelly for medical purposes; isotopes for medical purposes; dietetic substances of low sugar and salt adapted for medical use; chemical preparations as medicines for medical purposes, namely, for anti-tumor treatment; chemical reagents for medical purposes for the treatment of human illnesses; contact lens cleaning preparations; enzymes for medical purposes; enzyme preparations for medical purposes; amino acids for medical purposes; antibiotics; bronchodilating preparations; medicinal hair growth preparations; adjuvants for medical purposes; stem cells for medical purposes; biological tissue cultures for medical purposes; medicated eye-washes; antioxidant pills for medical use; protein dietary supplements; reagent paper for medical purposes; pesticides; diagnostic biomarker reagents for medical purposes; phytotherapy preparations for medical purposes; pre-filled syringes of medicines for medical treatment purposes, namely, anti-tumor treatment; reagent paper for veterinary purposes; astringents for medical purposes; insecticidal veterinary washes; capsules made of dendrimer-based polymers for medicinal preparations for the mouth, for pharmaceuticals purposes; raw material drugs, namely, pharmaceuticals for anti-tumor treatment; Chinese medicine nostrum for the treatment of tumors in humans; pharmaceutical blood preparations, namely, a blood clotting aid and delivery system for use in human medicine; rubbing alcohol; agricultural fungicide; eye drops; insect killing preparations in the nature of pesticides; pharmaceutical preparation for application to the eye or intraocular surgery for the purpose of anti-tumor treatment; ophthalmic pharmaceutical products for anti-tumor treatment; ophthalmic preparations; candy for pharmaceutical purpose for treatment of the cough; bacteriological research preparation, namely, preparations of reports for anti-tumor treatment for medical purposes; bacterial preparations for medical purposes for researching of human illnesses; medical probiotic supplements; medical diagnosis reagent; vaccine preparations; contact lenses care solution; contact lens disinfectant; biological agents for the treatment of cancer
35 Publicity consultation and agency services in the field of medicines; provision of goods sales information, namely, sales information about goods for anti-tumor treatment; retail store services featuring pharmaceutical, sanitary preparations and medical supplies; wholesale distributorships featuring pharmaceutical preparations, sanitary preparations, and medical supplies; retail store services and wholesale store services featuring pharmaceutical drugs; retail store services and wholesale store services featuring medicinal preparations; retail store services and wholesale store services featuring sanitary preparations; retail store services and wholesale store services featuring medical supplies
The mark consists of the wording "DIZAL" above four Chinese Characters. To the left of the wording is a design of two curved bands.
The non-Latin characters in the mark transliterate to "DI", "ZHE", "DI ZHE", "YI", "YAO" and "YI YAO" and this means "Enlightenment", "Philosophy", "Medical", "Medicine" and "Pharmaceutical" in English.
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "YI YAO"
Nov 1, 2022
Notice Of Registration Confirmation Emailed
Nov 1, 2022
Registered-Principal Register
Sep 30, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 28, 2022
Electronic Record Review Complete
Sep 23, 2022
On Hold - Electronic Record Review Required
Sep 20, 2022
Notice Of Acceptance Of Statement Of Use E-Mailed
Sep 18, 2022
Allowed Principal Register - Sou Accepted
Sep 16, 2022
Statement Of Use Processing Complete
Aug 31, 2022
Use Amendment Filed
Sep 14, 2022
Case Assigned To Intent To Use Paralegal
Aug 31, 2022
Teas Statement Of Use Received
Mar 1, 2022
Noa E-Mailed - Sou Required From Applicant
Jan 4, 2022
Official Gazette Publication Confirmation E-Mailed
Jan 4, 2022
Published For Opposition
Dec 15, 2021
Notification Of Notice Of Publication E-Mailed
Nov 24, 2021
Approved For Pub - Principal Register
Nov 22, 2021
Teas/Email Correspondence Entered
Nov 22, 2021
Correspondence Received In Law Office
Nov 22, 2021
Teas Response To Office Action Received
Oct 14, 2021
Notification Of Non-Final Action E-Mailed
Oct 14, 2021
Non-Final Action E-Mailed
Oct 14, 2021
Non-Final Action Written
Oct 12, 2021
Previous Allowance Count Withdrawn
Oct 5, 2021
Withdrawn From Pub - Og Review Query
Sep 16, 2021
Approved For Pub - Principal Register
Sep 11, 2021
Teas/Email Correspondence Entered
Sep 10, 2021
Correspondence Received In Law Office
Sep 10, 2021
Teas Request For Reconsideration Received
Sep 3, 2021
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 3, 2021
Teas Change Of Correspondence Received
Sep 3, 2021
Teas Change Of Domestic Representatives Address
Sep 3, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 3, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 3, 2021
Teas Change Of Owner Address Received
Mar 12, 2021
Notification Of Final Refusal Emailed
Mar 12, 2021
Final Refusal E-Mailed
Mar 12, 2021
Final Refusal Written
Mar 3, 2021
Teas/Email Correspondence Entered
Mar 2, 2021
Correspondence Received In Law Office
Mar 2, 2021
Teas Response To Office Action Received
Mar 1, 2021
Notification Of Non-Final Action E-Mailed
Mar 1, 2021
Non-Final Action E-Mailed
Mar 1, 2021
Non-Final Action Written
Feb 22, 2021
Assigned To Examiner
Nov 13, 2020
Notice Of Design Search Code E-Mailed
Nov 12, 2020
New Application Office Supplied Data Entered In Tram
Oct 2, 2020
New Application Entered In Tram
Trademark Alertz updated from USPTO on 2030-01-24
